KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Return on Invested Capital: 2024-2025

Historic Return on Invested Capital for Acadia Pharmaceuticals (ACAD) over the last 2 years, with Sep 2025 value amounting to 0.26%.

  • Acadia Pharmaceuticals' Return on Invested Capital rose 7.00% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26%, marking a year-over-year increase of 7.00%. This contributed to the annual value of 0.35% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Acadia Pharmaceuticals' Return on Invested Capital is 0.26%, which was up 6.85% from 0.25% recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Return on Invested Capital ranged from a high of 0.31% in Q4 2024 and a low of 0.03% during Q2 2024.
  • In the last 2 years, Acadia Pharmaceuticals' Return on Invested Capital had a median value of 0.26% in 2025 and averaged 0.22%.
  • Data for Acadia Pharmaceuticals' Return on Invested Capital shows a peak YoY increased of 22bps (in 2025) over the last 5 years.
  • Acadia Pharmaceuticals' Return on Invested Capital (Quarterly) stood at 0.31% in 2024, then climbed by 7bps to 0.26% in 2025.
  • Its Return on Invested Capital was 0.26% in Q3 2025, compared to 0.25% in Q2 2025 and 0.27% in Q1 2025.